Treatment for high-risk smoldering myeloma

N Engl J Med. 2013 Oct 31;369(18):1762-3. doi: 10.1056/NEJMc1310911.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Dexamethasone / therapeutic use*
  • Female
  • Humans
  • Male
  • Multiple Myeloma / drug therapy*
  • Thalidomide / analogs & derivatives*

Substances

  • Thalidomide
  • Dexamethasone